
Sign up to save your podcasts
Or


Mucus plugging is a challenge in asthma care. It’s thick, sticky mucus that blocks the airways and doesn’t respond to regular inhalers. Even when inflammation improves, these plugs can lower lung function, limit how well medicine works, and make asthma harder to control.
In this episode, we break down the study: “Effect of Dupilumab on Mucus Burden in Patients with Moderate-to-Severe Asthma,” published October 28, 2025. The analysis looks at whether dupilumab (Dupixent), a biologic that blocks IL-4 and IL-13, can lower mucus burden and improve lung function, especially in people who start with a high “mucus plug score.”
📌INFOGRAPHIC to follow along
RESOURCES:
What is asthma?
What is type 2 inflammation?
When Asthma Is More Than Just Asthma: Type 2 Inflammation
More about dupilumab (Dupixent)
The Itch Review, hosted by Dr. Gupta, Kortney, and Dr. Blaiss, explores allergy and immunology studies, breaking down complex research in conversations accessible to clinicians, patients, and caregivers. Each episode provides key insights from journal articles and includes a one-page infographic in the show notes for easy reference.
___
A special collaboration with the American Thoracic Society.
This podcast was made in partnership with Allergy & Asthma Network.
This podcast is for informational purposes only and does not substitute professional medical advice. Always consult with your healthcare provider for any medical concerns.
By The Itch: Allergies, Asthma & Immunology4.3
9292 ratings
Mucus plugging is a challenge in asthma care. It’s thick, sticky mucus that blocks the airways and doesn’t respond to regular inhalers. Even when inflammation improves, these plugs can lower lung function, limit how well medicine works, and make asthma harder to control.
In this episode, we break down the study: “Effect of Dupilumab on Mucus Burden in Patients with Moderate-to-Severe Asthma,” published October 28, 2025. The analysis looks at whether dupilumab (Dupixent), a biologic that blocks IL-4 and IL-13, can lower mucus burden and improve lung function, especially in people who start with a high “mucus plug score.”
📌INFOGRAPHIC to follow along
RESOURCES:
What is asthma?
What is type 2 inflammation?
When Asthma Is More Than Just Asthma: Type 2 Inflammation
More about dupilumab (Dupixent)
The Itch Review, hosted by Dr. Gupta, Kortney, and Dr. Blaiss, explores allergy and immunology studies, breaking down complex research in conversations accessible to clinicians, patients, and caregivers. Each episode provides key insights from journal articles and includes a one-page infographic in the show notes for easy reference.
___
A special collaboration with the American Thoracic Society.
This podcast was made in partnership with Allergy & Asthma Network.
This podcast is for informational purposes only and does not substitute professional medical advice. Always consult with your healthcare provider for any medical concerns.

78,397 Listeners

7,236 Listeners

14,978 Listeners

260 Listeners

3,364 Listeners

1,456 Listeners

3,512 Listeners

9,265 Listeners

51 Listeners

35,740 Listeners

50 Listeners

220 Listeners

29,265 Listeners

4,510 Listeners

19,909 Listeners